Cargando…
Rho/ROCK acts downstream of lysophosphatidic acid receptor 1 in modulating P2X(3) receptor-mediated bone cancer pain in rats
BACKGROUND: Lysophosphatidic acid receptor 1 and Rho/ROCK signaling is implicated in bone cancer pain development. However, it remains unknown whether the two signaling pathways function together in P2X(3) receptor-mediated bone cancer pain. RESULTS: In this study, using a rat model of bone cancer,...
Autores principales: | Wu, Jing-xiang, Yuan, Xiao-min, Wang, Qiong, Wei, Wang, Xu, Mei-ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956381/ https://www.ncbi.nlm.nih.gov/pubmed/27094551 http://dx.doi.org/10.1177/1744806916644929 |
Ejemplares similares
-
Rho-Kinase/ROCK Phosphorylates PSD-93 Downstream of NMDARs to Orchestrate Synaptic Plasticity
por: Hossen, Emran, et al.
Publicado: (2022) -
Chemokine receptor CXCR4 activates the RhoA/ROCK2 pathway in spinal neurons that induces bone cancer pain
por: Xu, Heng, et al.
Publicado: (2020) -
Enhancement of P2X3 Receptor-Mediated Currents by Lysophosphatidic Acid in Rat Primary Sensory Neurons
por: Qiao, Wen-Long, et al.
Publicado: (2022) -
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017) -
Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009)